Synergistic combinations of guanosine analog reverse transcriptase inhibitors and inosine monophosphate dehydrogenese inhibitors and uses therefor
US6514979B1 · kind B1 · utility
0Cited by
31References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 3, 1999 |
| Grant date | Feb 4, 2003 |
| Priority date | — |
| Expiry date | Mar 3, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/52
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Synergistic combinations of guanosine nucleoside analog reverse transcriptase inhibitors such as abacavir with inosine monophosphate dehydrogenase inhibitors such as mycophenolates, pharmaceutical compositions comprising such combinations, and therapeutic methods comprising administering the synergistic combinations to subjects in need thereof, for treating a viral infection, such as an HIV-1 infection.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.